Company Filing History:
2 out of 1,503 
2 out of 173 
Years Active: 2009-2011
Title: Inventor Spotlight: Johanna Lindquist
Introduction
Johanna Lindquist is an innovative inventor based in Södertälje, Sweden, with a remarkable focus on the field of biotechnology. With two patents under her name, she has made significant contributions to medical research, particularly in the area of antibody development.
Latest Patents
Johanna's latest patents focus on methods of using an antibody that binds to apolipoprotein E. This includes a human antibody fragment that is designed to effectively bind to a polypeptide with the amino acid sequence of the C-terminal domain of Apolipoprotein E (ApoE-CTD) and human plaques. Her research holds considerable potential for advancing treatment options for conditions associated with lipid metabolism and Alzheimer's disease.
Career Highlights
Throughout her career, Johanna has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, she has been associated with AstraZeneca AB and Dyax Corporation, where her research has rapidly advanced the understanding of antibody applications.
Collaborations
Johanna has collaborated with esteemed colleagues such as Christer Nordstedt and Tom Goldschmidt, further enhancing her innovative projects. These partnerships have allowed her to leverage multidisciplinary expertise, resulting in groundbreaking findings in her field.
Conclusion
Johanna Lindquist represents the ingenuity and determination of female inventors in the realm of biotechnology. With her patented inventions addressing critical health issues, she continues to inspire future generations of innovators and researchers. Her work not only underscores the importance of collaboration in scientific advancement but also reinforces the valuable impact of diverse perspectives in the field of invention.